GH Research GHRS
NASDAQ GHRS
$22.84 -0.02 (-0.07%)
As of: Oct 2, 2026 · 3:20 PM EDT

GH Research (GHRS) Net Equity Issued and Repurchased (2025 - 2026)

Updated

GH Research's Net Equity Issued and Repurchased was $117.97 million in Q2 2026.

Analysis

GH Research (GHRS) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, GH Research's Net Equity Issued and Repurchased was $118.04 million through Jun 30, 2026, down 21.3% year-over-year; for FY2025, it came in at $150 million.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 93.7% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $309.2 million in FY2021.
  • The Q2 2026 figure marks the highest quarterly Net Equity Issued and Repurchased since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 GH Research 1.46 Bn 296.11 Mn - 117.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 117.97 Mn
Mar 31, 2026 72,000.00
Mar 31, 2025 150.00 Mn
API Access

GH Research Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GHRS&period=max&api_key=YOUR_API_KEY